Answers are grounded in this paper and cite their sources.
Targeted nanomedicine strategies offer improved selectivity, reduced toxicity, and personalized interventions in blood cancer treatment by integrating advanced carriers, ligand-based targeting, and AI-powered optimization.
No takes yet. Share an insight, caveat, or question.
Adeyemi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: